GleamWall
中文EN

MRK Merck & Co., Inc.

Pharmaceutical Preparations · NYSE · SEC CIK 310158 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.9%
TTM net income YoY-87.1%
TTM EPS YoY-86.9%
Revenue 3-yr CAGR4.3%
Net income 3-yr CAGR-19.0%

Margins

Gross margin71.8%
Operating margin—
Net margin3.6%
FCF margin21.9%
EBITDA margin—

Returns

ROE5.1%
ROA1.9%
ROIC (approx.)—
Asset turnover0.51x

Leverage & solvency

Liabilities / assets66.1%
Debt / equity1.20x
Current ratio1.35x
Interest coverage—

Cash quality & payout

Operating cash flow / net income7.62x
Accruals ratio-12.4%
Payout ratio341.1%
Capex / revenue5.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$65.01B$64.17B
Cost of revenue$16.38B$15.19B
Gross profit$48.63B$48.98B
R&D expense$15.79B$17.94B
SG&A expense$10.73B$10.82B
Interest expense$1.36B$1.27B
Pretax income$21.07B$19.94B
Income tax$2.80B$2.80B
Net income$18.25B$17.12B
EPS (basic)7.306.76
EPS (diluted)7.286.74
Dividends declared per share3.283.12
Weighted avg. shares (diluted)2.51B2.54B
Balance sheet
Cash & equivalents$14.56B$13.32B
Short-term investments$0$447.00M
Receivables$11.78B$10.28B
Inventory$6.66B$6.11B
Current assets$43.52B$38.78B
PP&E, net$25.32B$23.78B
Goodwill$21.58B$21.67B
Intangibles$26.68B$16.37B
Total assets$136.87B$117.11B
Current liabilities$28.33B$28.42B
Short-term debt$2.59B$2.65B
Long-term debt$46.75B$34.46B
Total debt$49.34B$37.11B
Total liabilities$84.20B$70.73B
Shareholders' equity$52.61B$46.31B
Net debt$34.77B$23.79B
Cash flow statement
Operating cash flow$16.47B$21.47B
Capital expenditure$4.11B$3.37B
Free cash flow$12.36B$18.10B
Investing cash flow-$13.74B-$7.73B
Financing cash flow-$1.92B-$7.03B
Depreciation & amortization$3.04B$2.10B
Stock-based compensation$820.00M$761.00M
Dividends paid$8.18B$7.84B
Share buybacks$5.08B$1.31B

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.